Literature DB >> 14724065

Study of factors influencing the decreased HDL associated PON1 activity with aging.

Ildiko Seres1, Gyorgy Paragh, Elaine Deschene, Tamas Fulop, Abdelouahed Khalil.   

Abstract

Paraoxonase (PON1) is principally complexed to HDL and is responsible, at least in part, for its antioxidant properties. PON1 activity decreases in several pathologies associated with atherosclerosis. The aim of this study was to investigate the PON1 activity and factors influencing its activity as a function of age. One hundred and twenty nine healthy subjects aged between 22 and 89 years were recruited for the study. We found that serum PON1 activity significantly decreased with age (r=-0.38, p<0.0001) while its arylesterase activity as well as its concentration in the serum did not change significantly. HDL concentrations remained unchanged with age, however, Apo A1 concentration showed a slight negative but significant correlation with age (r=-0.19, p<0.027). Moreover, the total cholesterol concentration was positively and significantly correlated with age (r=0.40, p<0.001). Thus, our results suggest that the decrease in PON1 activity cannot be explained by the decrease in Apo A1 concentrations with age. HDL from elderly subjects was more susceptible to oxidation than HDL from young subjects measured by higher lipid peroxidation rate. Thus, the decrease in PON1 activity may contribute to this increased susceptibility of HDL to oxidation with aging. Altogether our results suggest that the decrease in PON1 activity may be related to the development of oxidative stress conditions with aging and the increased HDL susceptibility to oxidation in elderly subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724065     DOI: 10.1016/j.exger.2003.08.001

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  32 in total

1.  HDL anti-oxidant function associates with LDL level in young adults.

Authors:  Carrie V Breton; Fen Yin; Xinhui Wang; Ed Avol; Frank D Gilliland; Jesus A Araujo
Journal:  Atherosclerosis       Date:  2013-11-15       Impact factor: 5.162

2.  The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Authors:  Mahmut Abuhandan; Alpay Cakmak; Abdullah Taskın; Emrah Karakaya; Abdurrahim Kocyigit; Hatip Kılıc
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Authors:  Maria Fernanda Martínez-Salazar; Damianys Almenares-López; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Alina Juantorena-Ugás; Camilo Ríos; Antonio Monroy-Noyola
Journal:  Genes Nutr       Date:  2011-03-25       Impact factor: 5.523

4.  Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.

Authors:  H Karsen; I Binici; M Sunnetcioglu; A I Baran; M R Ceylan; S Selek; H Celik
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 5.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 6.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

7.  Oxidative stress in chronic otitis media.

Authors:  Elif Baysal; Nurten Aksoy; Ferit Kara; Seyithan Taysi; Abdullah Taşkın; Hasan Bilinç; Cengiz Cevik; Fatih Celenk; Muzaffer Kanlıkama
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-19       Impact factor: 2.503

8.  Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population.

Authors:  Ufuk Cakatay; Refik Kayali; Hafize Uzun
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

9.  Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

Authors:  Yuhua Sun; Yuejin Yang; Weidong Pei; Yongjian Wu; Jinglin Zhao
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

10.  Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.

Authors:  Karen Huen; Kim Harley; Jordan Brooks; Alan Hubbard; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.